| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Gc Corp. is 10% Owner at ARTV.
Net of sales, the ARTV filings show accumulation of 3,515,623 shares.
Gc Corp. has 2 Form 4 filings on record from July 2024 to May 2026, all as 10% Owner at Artiva Biotherapeutics (ARTV), 2024–2026.
The 10 reported transactions were 4 open-market purchases, 4 conversions and 2 other transactions.
Counted by filing, the open-market trades come to 2 purchases worth about $41.5M and no sales.
The largest open-market purchase was 2,083,332 shares of ARTV at an average $12.00 on July 22, 2024, about $25.0M. Twelve months later ARTV was down 78%.